Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-006257
Filing Date
2022-02-14
Accepted
2022-02-14 18:26:04
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 21291
  Complete submission text file 0000899243-22-006257.txt   22613
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address
Robb Gary Charles (Reporting) CIK: 0001529655 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-50679 | Film No.: 22635865